|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/14/22 Lilium N.V. F-1 167:21M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: F-1 Registration Statement by a Foreign Issuer HTML 3.07M
2: EX-5.1 Opinion of Counsel re: Legality HTML 83K
3: EX-8.1 Opinion of Counsel re: Tax Matters HTML 48K
4: EX-8.2 Opinion of Counsel re: Tax Matters HTML 55K
5: EX-8.3 Opinion of Counsel re: Tax Matters HTML 56K
6: EX-23.4 Consent of Expert or Counsel HTML 42K
7: EX-FILING FEES Filing Fees HTML 47K
13: R1 Document and Entity Information HTML 52K
14: R2 Consolidated Statements of Operations and Other HTML 114K
Comprehensive Income (Loss)
15: R3 Consolidated Statement of Financial Position HTML 130K
16: R4 Consolidated Statement of Changes in Equity HTML 84K
17: R5 Consolidated Statement of Cash Flows HTML 143K
18: R6 Corporate Information HTML 69K
19: R7 Basis of Preparation HTML 100K
20: R8 Significant Accounting Policies HTML 138K
21: R9 Significant Accounting Judgments, Estimates and HTML 64K
Assumptions
22: R10 Revenue from Contracts with Customers and Cost of HTML 44K
Sales
23: R11 Research and Development Expenses HTML 60K
24: R12 General and Administrative Expenses HTML 62K
25: R13 Selling Expenses HTML 58K
26: R14 Other Income HTML 58K
27: R15 Other Expenses HTML 53K
28: R16 Financial Result HTML 62K
29: R17 Income Taxes HTML 152K
30: R18 Loss per Share HTML 56K
31: R19 Intangible Assets HTML 102K
32: R20 Property, Plant and Equipment HTML 191K
33: R21 Leases HTML 123K
34: R22 Investment in Associated Companies HTML 74K
35: R23 Other Financial Assets HTML 59K
36: R24 Non-Financial Assets HTML 56K
37: R25 Cash and Cash Equivalents HTML 51K
38: R26 Shareholders' Equity HTML 104K
39: R27 Share-based Payments HTML 322K
40: R28 Warrants, Convertible Loans and Other Financial HTML 77K
Liabilities
41: R29 Provisions HTML 75K
42: R30 Post-Employment Benefits HTML 159K
43: R31 Trade and other Payables HTML 54K
44: R32 Other Non-Financial Liabilities HTML 53K
45: R33 Financial Instruments HTML 365K
46: R34 Commitments and Contingencies HTML 45K
47: R35 Related Party Disclosures HTML 93K
48: R36 Events after the Reporting Period HTML 45K
49: R37 Significant Accounting Policies (Policies) HTML 172K
50: R38 Corporate Information (Tables) HTML 61K
51: R39 Basis of Preparation (Tables) HTML 94K
52: R40 Significant Accounting Policies (Tables) HTML 53K
53: R41 Research and Development Expenses (Tables) HTML 58K
54: R42 General and Administrative Expenses (Tables) HTML 60K
55: R43 Selling Expenses (Tables) HTML 57K
56: R44 Other Income (Tables) HTML 56K
57: R45 Other Expenses (Tables) HTML 52K
58: R46 Financial Result (Tables) HTML 60K
59: R47 Income Taxes (Tables) HTML 153K
60: R48 Loss per Share (Tables) HTML 54K
61: R49 Intangible Assets (Tables) HTML 101K
62: R50 Property, Plant and Equipment (Tables) HTML 192K
63: R51 Leases (Tables) HTML 129K
64: R52 Investment in Associated Companies (Tables) HTML 70K
65: R53 Other Financial Assets (Tables) HTML 55K
66: R54 Non-Financial Assets (Tables) HTML 55K
67: R55 Cash and Cash Equivalents (Tables) HTML 50K
68: R56 Shareholders' Equity (Tables) HTML 93K
69: R57 Share-based Payments (Tables) HTML 325K
70: R58 Warrants, Convertible Loans and Other Financial HTML 72K
Liabilities (Tables)
71: R59 Provisions (Tables) HTML 74K
72: R60 Post-Employment Benefits (Tables) HTML 165K
73: R61 Trade and other Payables (Tables) HTML 53K
74: R62 Other Non-Financial Liabilities (Tables) HTML 52K
75: R63 Financial Instruments (Tables) HTML 363K
76: R64 Related Party Disclosures (Tables) HTML 85K
77: R65 Corporate Information (Details) HTML 63K
78: R66 Corporate Information - The Reorganization HTML 64K
(Details)
79: R67 Basis of Preparation (Details) HTML 60K
80: R68 Significant Accounting Policies - Purchase of HTML 52K
intangible assets (Details)
81: R69 Significant Accounting Policies - Estimated useful HTML 59K
lives of property plant and equipment (Details)
82: R70 Significant Accounting Policies (Details) HTML 49K
83: R71 Significant Accounting Policies - Share-based HTML 200K
Payments (Details)
84: R72 Significant Accounting Judgments, Estimates and HTML 48K
Assumptions (Details)
85: R73 Significant Accounting Judgments, Estimates and HTML 55K
Assumptions - Investment in associate - Purchase
Price Allocation (Details)
86: R74 Significant Accounting Judgments, Estimates and HTML 52K
Assumptions - Share-based Payments (Details)
87: R75 Revenue from Contracts with Customers and Cost of HTML 44K
Sales (Details)
88: R76 Research and Development Expenses (Details) HTML 60K
89: R77 Research and Development Expenses - Additional HTML 47K
Information (Details)
90: R78 General and Administrative Expenses (Details) HTML 65K
91: R79 General and Administrative Expenses - Additional HTML 48K
Information (Details)
92: R80 Selling Expenses (Details) HTML 60K
93: R81 Other Income (Details) HTML 58K
94: R82 Other Expenses (Details) HTML 49K
95: R83 Financial Result (Details) HTML 58K
96: R84 Financial Result - Additional Information HTML 61K
(Details)
97: R85 Income Taxes - Expense for Income Tax Expense HTML 52K
(Details)
98: R86 Income Taxes - Income Tax Expense (Details) HTML 49K
99: R87 Income Taxes - Reconciliation of expected tax HTML 88K
expense (Details)
100: R88 Income Taxes - Tax Rate Reconciliation (Details) HTML 56K
101: R89 Income Taxes - Deferred tax related to Assets and HTML 89K
Liabilities (Details)
102: R90 Income Taxes - Tax attributes (Gross) (Details) HTML 48K
103: R91 Income Taxes - Deductible temporary differences HTML 57K
and tax loss and interest carryforwards (Details)
104: R92 Loss per Share (Details) HTML 55K
105: R93 Intangible Assets (Details) HTML 78K
106: R94 Intangible Assets - Additional Information HTML 43K
(Details)
107: R95 Property, Plant and Equipment (Details) HTML 105K
108: R96 Property, Plant and Equipment - Property, plant HTML 56K
and equipment is distributed among geographical
areas (Details)
109: R97 Leases - Right-of-use assets (Details) HTML 67K
110: R98 Leases - Lease liabilities (Details) HTML 51K
111: R99 Leases - Related expense (Details) HTML 53K
112: R100 Leases - Lease liabilities (Details) HTML 48K
113: R101 Leases - Total cash outflow (Details) HTML 49K
114: R102 Investment in Associated Companies (Details) HTML 67K
115: R103 Investment in Associated Companies - Valuation of HTML 53K
investment in Zenlabs (Details)
116: R104 Investment in Associated Companies - Financial HTML 99K
information for Zenlabs (Details)
117: R105 Other Financial Assets - Other financial assets HTML 57K
(Details)
118: R106 Other Financial Assets - Fixed term deposit HTML 96K
(Details)
119: R107 Non-Financial Assets (Details) HTML 57K
120: R108 Non-Financial Assets - Prepaid expenses (Details) HTML 45K
121: R109 Cash and Cash Equivalents (Details) HTML 49K
122: R110 Shareholders' Equity (Details) HTML 101K
123: R111 Shareholders' Equity - Additional information HTML 199K
(Details)
124: R112 Share-based Payments - Other plans (Details) HTML 67K
125: R113 Share-based Payments - expense recognized for HTML 220K
participant services (Details)
126: R114 Share-based Payments - Measurement of fair values HTML 191K
(Details)
127: R115 Warrants, Convertible Loans and Other Financial HTML 53K
Liabilities (Details)
128: R116 Warrants, Convertible Loans and Other Financial HTML 69K
Liabilities - Additional information (Details)
129: R117 Warrants, Convertible Loans and Other Financial HTML 61K
Liabilities - equity effect (Details)
130: R118 Provisions (Details) HTML 70K
131: R119 Post-Employment Benefits (Details) HTML 46K
132: R120 Post-Employment Benefits - Present value of the HTML 48K
defined benefit obligations and the fair value of
the plan assets (Details)
133: R121 Post-Employment Benefits - Reconciliation of the HTML 55K
net defined benefit liability (Details)
134: R122 Post-Employment Benefits - Reconciliation of the HTML 74K
amount recognized in the consolidated statement of
financial position (Details)
135: R123 Post-Employment Benefits - Reconciliation of the HTML 65K
plan assets (Details)
136: R124 Post-Employment Benefits - Expense recognized in HTML 74K
the consolidated statements of operations and
other comprehensive income (Details)
137: R125 Post-Employment Benefits - Principal actuarial HTML 50K
assumptions (Details)
138: R126 Post-Employment Benefits - Sensitivity Analysis HTML 57K
(Details)
139: R127 Post-Employment Benefits - Expected Benefit HTML 52K
Payments (Details)
140: R128 Trade and other Payables (Details) HTML 54K
141: R129 Other Non-Financial Liabilities (Details) HTML 52K
142: R130 Financial Instruments - Financial assets, by class HTML 69K
(Details)
143: R131 Financial Instruments - Financial liabilities, by HTML 64K
class (Details)
144: R132 Financial Instruments - Thereof aggregated to HTML 59K
categories according to IFRS 9 (Details)
145: R133 Financial Instruments - Effect of reasonable HTML 66K
changes of the most significant input parameters
on the fair values of the embedded derivatives
(Details)
146: R134 Financial Instruments - Financial instruments, HTML 72K
changes in Fair Value of level 3 instruments
(Details)
147: R135 Financial Instruments - Net gains and losses for HTML 68K
each of the financial instrument measurement
categories (Details)
148: R136 Financial Instruments - carrying amount of HTML 56K
monetary assets and liabilities (Details)
149: R137 Financial Instruments - Interest Rate Risk HTML 47K
(Details)
150: R138 Financial Instruments - Other Price Risk (Details) HTML 68K
151: R139 Financial Instruments - Financial Instrument Risk HTML 87K
Management Objectives and Policies (Details)
152: R140 Financial Instruments - Reconciliation of changes HTML 76K
in liabilities arising from financing activities
(Details)
153: R141 Commitments and Contingencies - Lease contracts HTML 62K
(Details)
154: R142 Related Party Disclosures (Details) HTML 49K
155: R143 Related Party Disclosures - Transactions with Key HTML 49K
Management (Details)
156: R144 Related Party Disclosures - Annual remuneration HTML 63K
and related compensation costs recognized as
expense (Details)
157: R145 Related Party Disclosures - Balances held by HTML 67K
entities with significant influence over the
company (Details)
158: R146 Related Party Disclosures - Transactions with HTML 58K
related parties (Details)
159: R147 Related party Disclosures - Convertible Loan HTML 60K
(Details)
160: R148 Related party Disclosures - Strategic Commercial HTML 57K
Collaboration (Details)
161: R149 Related Party Disclosures - Transactions with HTML 60K
Shareholders (Details)
162: R150 Events after the Reporting Period (Details) HTML 46K
165: XML IDEA XML File -- Filing Summary XML 324K
163: XML XBRL Instance -- lilm-20220328xf1_htm XML 6.08M
164: EXCEL IDEA Workbook of Financial Reports XLSX 233K
9: EX-101.CAL XBRL Calculations -- lilm-20220328_cal XML 227K
10: EX-101.DEF XBRL Definitions -- lilm-20220328_def XML 1.27M
11: EX-101.LAB XBRL Labels -- lilm-20220328_lab XML 2.55M
12: EX-101.PRE XBRL Presentations -- lilm-20220328_pre XML 1.93M
8: EX-101.SCH XBRL Schema -- lilm-20220328 XSD 507K
166: JSON XBRL Instance as JSON Data -- MetaLinks 605± 919K
167: ZIP XBRL Zipped Folder -- 0001104659-22-071040-xbrl Zip 754K
EXHIBIT 5.1
Lilium N.V. Claude-Dornier-Straße 1 Building 335 82234 Wessling Germany | | | Amsterdam Freshfields Bruckhaus Deringer LLP Strawinskylaan 10 T+31 20 485 7000 +31 20 485 7633 (Direct) F+31 20 517 7633 E dirkjan.smit@freshfields.com | |||||
| | | | |||||
14 June 2022 | | |||||||
Dear Sirs, Madams,
Introduction
1.We have acted as Dutch law legal advisers to Lilium N.V. (the Company) with respect to certain matters of Netherlands law in connection with, inter alia, the issuance by the Company of up to 21,691,268 class A ordinary shares in the capital of the Company, having a nominal value of € 0.12 each (the New Shares) to Tumim Stone Capital LLC (the Investor) on the terms and conditions set out in the share purchase agreement entered into by and among the Company and the Investor, dated 3 June 2022 (the Share Purchase Agreement). Pursuant to the Share Purchase Agreement, the Company also entered into a registration rights agreement with the Investor, dated 3 June 2022 (the Registration Rights Agreement), pursuant to which the Company agreed, among other things, to register the offer and sale by the Investor of the New Shares under the United States Securities Act of 1933, as amended (the Securities Act) (the Transaction).
This opinion letter is delivered to you pursuant to your request.
Documents reviewed
2. | In rendering the opinion, we have examined the following documents: |
(a) | the registration statement on Form F-1 under the Securities Act, as filed with the Securities and Exchange Commission (the Commission) on 14 June 2022 (the Registration Statement); |
(b) | an electronic copy of an extract from the commercial register of the Dutch Chamber of Commerce (the Commercial Register) dated 14 June 2022 relating to the Company, |
Freshfields Bruckhaus Deringer LLP is a limited liability partnership registered in England and Wales with registered number OC334789. It is authorised and regulated by the Solicitors Regulation Authority. Dutch Chambers of Commerce registration number 34368197. For regulatory information please refer to www.freshfields.com/support/legalnotice.
A list of the members (and of the non-members who are designated as partners) of Freshfields Bruckhaus Deringer LLP and their qualifications is available for inspection at its registered office, 65 Fleet Street, London EC4Y 1HS or at the above address. Any reference to a partner means a member, or a consultant or employee with equivalent standing and qualifications, of Freshfields Bruckhaus Deringer LLP or any of its affiliated firms or entities. Freshfields Bruckhaus Deringer LLP’s Amsterdam office includes attorneys, civil law notaries, tax advisers and solicitors.
Bank account:
Stg Beh Derdengld Freshfields Bruckhaus Deringer LLP, ABN AMRO Bank N.V., IBAN: NL14ABNA0256049947, BIC: ABNANL2A
Abu
Dhabi Amsterdam Bahrain Beijing Berlin Brussels Cologne Dubai Düsseldorf Frankfurt am Main Hamburg Hanoi Ho Chi Minh City Hong Kong
London Madrid Milan Munich New York Paris Rome Shanghai Singapore Tokyo Vienna Washington
2/9
and confirmed upon our request by the Commercial Register by telephone to be correct in all material respects on the date hereof (the Extract);
(c) | a scanned copy of the deed of incorporation of the Company (at the time named Qell DutchCo B.V.) dated 11 March 2021 (the Deed of Incorporation); |
(d) | a scanned copy of the deed of partial amendment of the articles of association of the Company (akte van partiële statutenwijziging) dated 8 April 2021, pursuant to which amendment the name of the Company was changed into Lilium B.V.; |
(e) | a scanned copy of a deed of conversion and amendment (akte van omzetting en statutenwijziging) dated 22 September 2021 relating to the conversion of the legal form of the Company from a company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) into a public company (naamloze vennootschap) and amendment of the articles of association (statuten) of the Company, which, according to the Extract, are the Company’s articles of association currently in force and effect (the Articles of Association); |
(f) | copies of: |
(i) | resolution of the general meeting of the Company dated 10 September 2021 (the Shareholder’s Resolution) relating to, inter alia, the designation of the board of directors of the Company (the Board) (a) to issue (or to grant rights to subscribe for) class A ordinary shares and class B ordinary shares in the capital of the Company up to a maximum of 25% of the outstanding capital after the Deeds of Issue (as defined in the Shareholder’s Resolution) became effective (i.e., on 14 September 2021) for a period of 5 years as of the date of the Shareholder’s Resolution and (b) to limit or exclude pre-emptive rights with regard to such issuances of (or rights to subscribe for) class A ordinary shares and class B ordinary shares in the capital of the Company pursuant to the delegation referred to above under (a); and |
(ii) | unanimous resolution of the board of directors of the Company (the Board) dated 31 May 2022 (Board Resolution); |
(g) | draft dated 3 June 2022 of the instruction notice from the Company to Continental Stock Transfer & Trust Company (as transfer agent) relating to the issuance and delivery of the New Shares (the Instruction Notice); |
(h) | the Share Purchase Agreement; and |
(i) | the Registration Rights Agreement. |
The documents referred to above in items (a) to (i) (inclusive) are herein referred to as the Documents; the documents referred to above in items (b) and (f) (inclusive) are herein referred to as the Corporate Documents; and the documents referred to above in item (f) are herein referred to as the Resolutions.
3/9
Nature of Opinion and Observations
3. | This opinion is subject to the following nature of opinion and observations: |
(a) | Dutch Law: this opinion is confined to the laws with general applicability (wettelijke regels met algemene gelding) of the Netherlands and, insofar as they are directly applicable in the Netherlands, the European Union, all as they stand as at the date hereof and as such laws are currently interpreted in published authoritative case law of the courts of the Netherlands (Dutch law); accordingly, we express no opinion with regard to any other system of law (including the law of jurisdictions other than the Netherlands in which our firm has an office), even in cases where, in accordance with Dutch law, any foreign law should be applied; furthermore, we do not express any opinion on public international law or on the rules of or promulgated under any treaty or by any treaty organisation (except as otherwise stated above); |
(b) | Changes in Law: we express no opinion that the future or continued performance of a party’s obligations or the consummation of the Transaction will not contravene Dutch law, its application or interpretation if altered in the future; |
(c) | Territory of the Netherlands: all references in this opinion letter and its schedules to the Netherlands and Dutch law are to the European part of the Netherlands and its law, respectively, only; |
(d) | Factual Statements: we have not been responsible for investigating or verifying the accuracy of the facts (or statements of foreign law) or the reasonableness of any statements of opinion or intention contained in any documents, or for verifying that no material facts or provisions have been omitted therefrom; nor have we verified the accuracy of any assumption made in this opinion letter; |
(e) | Representations: we express no opinion as to the correctness of any representation given by any of the parties (express or implied) under or by virtue of the Documents, save if and insofar as the matters represented are the subject matter of a specific opinion herein; |
(f) | Effects of Opinion: the opinions expressed in this opinion letter have no bearing on declarations made, opinions expressed or statements of a similar nature made by any of the parties in the Documents; |
(g) | Nature of Investigations: in rendering this opinion we have exclusively examined the Documents and we have conducted such investigations of Dutch law as we have deemed necessary or advisable for the purpose of giving this opinion letter; as to matters of fact we have relied on the Documents and any other document we have deemed relevant, and on statements or certificates of public officials; |
(h) | Formulae and Cash Flows: we have not been responsible for verifying the accuracy or correctness of any formula or ratio (whether expressed in words or symbols) or financial schedule contained in the Documents, or any cash flow model used or to be used in connection with the transactions contemplated thereby, or whether such formula, ratio, financial schedule or cash flow model appropriately reflects the commercial arrangements between the parties; |
4/9
(i) | Tax: we express no opinion in respect of the tax treatment of the Documents or the Transaction; you have not relied on any advice from us in relation to the tax implications of the Documents or the Transaction for any person, whether in the Netherlands or any other jurisdiction, or the suitability of any tax provisions in the Documents; |
(j) | Operational Licenses: we have not investigated whether the Company has obtained any of the operational licenses, permits and consents which it may require for the purpose of carrying on its business (including the Transaction); |
(k) | Anti-trust: we have not considered whether the transactions contemplated by the Documents comply with civil, regulatory or criminal anti-trust, cartel, competition, public procurement or state aid laws, nor whether any filings, clearances, notifications or disclosures are required or advisable under such laws; |
(l) | Data Protection: we express no opinion on any data protection or insider trading laws of any jurisdiction (including the Netherlands); |
(m) | Legal Concepts: Dutch legal concepts are expressed in English terms and not in their original Dutch terms; the concepts concerned may not be identical to the concepts described by the same English terms as they exist in the laws of other jurisdictions; |
(n) | Governing Law: this opinion and any non-contractual obligations arising out of or in relation to this opinion are governed by Dutch law; and |
(o) | Date of Opinion: this opinion speaks as of the date hereof; no obligation is assumed to update this opinion or to inform any person of any changes of law or other matters coming to our knowledge and occurring after the date hereof, which may affect this opinion in any respect. |
Opinion
4.On the basis stated in paragraph 3, and subject to the assumptions in Schedule 1, the qualifications in Schedule 2 and any factual matters, documents or events not disclosed to us, we are of the opinion that when issued pursuant to validly executed Instruction Notice(s) and fully paid in US Dollars (and following receipt by the Dutch notary of a bank statement as referred to in Section 2:93a paragraphs 2 and 6 of the Dutch Civil Code) in accordance with the terms of a validly executed Share Purchase Agreement and the Articles of Association, each New Share will have been duly authorised, validly issued and fully paid and will be non-assessable.
Benefit of opinion
5.This opinion is addressed to you in relation to and as an exhibit to the Company’s Registration Statement and, except with our prior written consent, is not to be transmitted or disclosed to any other person, other than as an exhibit to the Registration Statement and is not to be used or relied upon by you or by any other person for any purpose other than in connection with the filing of the Registration Statement.
6.This opinion letter and any non-contractual obligations arising out of or in relation to this opinion are governed by the laws of the Netherlands. Every situation concerning the legal
5/9
relationship between yourself and Freshfields Bruckhaus Deringer LLP, the above submission to jurisdiction included, is governed by the general terms of Freshfields Bruckhaus Deringer LLP.1
7.We hereby consent to the filing of this legal opinion letter as an exhibit to the Registration Statement. In giving the consent set out in the previous sentence, we do not thereby admit or imply that we are in the category of persons whose consent is required under Section 7 of the Securities Act or any rules and regulations of the SEC promulgated thereunder.
Yours faithfully,
/S/ Freshfields Bruckhaus Deringer LLP
Freshfields Bruckhaus Deringer LLP
1 The general terms and conditions of Freshfields Bruckhaus Deringer LLP can be found at www.freshfields.com.
6/9
Schedule 1
ASSUMPTIONS
In considering the Documents and in rendering this opinion we have (with your consent and, unless specifically stated otherwise, without any further enquiry) assumed that:
(a) | Authenticity: all (electronic) signatures, stamps and seals on all documents in connection with this opinion (whether as originals as copies or electronically) are genuine and all such documents are authentic, accurate and complete; |
(b) | Copies: all documents retrieved by us or supplied to us electronically (whether in portable document format (PDF) or as scanned copies), as photocopies, facsimile copies or e-mail conformed copies are in conformity with the originals; |
(c) | Drafts: Documents examined by us in draft form, as applicable, have been or, as the case may be, will be executed in the form of the drafts examined by us; |
(d) | No Amendments: the Documents have since their execution, as applicable, not been amended, supplemented, rescinded, terminated by any of the parties thereto or declared null and void by a competent court; |
(e) | Deed of Incorporation: the Deed of Incorporation is a valid notarial deed (authentieke akte), the contents of which were correct and complete as of the date thereof and there were no defects in the incorporation of the Company (not appearing on the face of the Deed of Incorporation) on the basis of which a court might dissolve the Company or deem it has never existed; |
(f) | Registration: the Registration Statement has been or will have been filed with the SEC and declared effective pursuant to the Securities Act; |
(g) | Corporate Documents: at the time when any Corporate Document was signed or will be signed, as the case may be, each person who is a party to or signatory of that Corporate Document, as applicable (i) had been validly incorporated, was validly existing and, to the extent relevant in such party’s jurisdiction, in good standing under the laws applicable to such party, (ii) had all requisite power, authority and legal capacity to sign that Corporate Document and to perform all juridical acts (rechtshandelingen) and other actions contemplated thereby and (iii) has validly signed that Corporate Document; |
(h) | Extract: the information set forth in the Extract is accurate and complete on the date hereof and the factual statements from the Company in relation to the total issued and outstanding capital of the Company are accurate and complete on the date hereof; |
(i) | No Insolvency: (a) the Company has not been declared bankrupt (failliet verklaard), (b) the Company has not been granted a (provisional) suspension of payments ((voorlopige) surseance van betaling), (c) the Company has not become subject to a (confidential or public) pre-insolvency private plan procedure (onderhands akkoordprocedure), (d) the Company has not become subject to any of the other insolvency proceedings (together with the proceedings in paragraph (h)(a), (h)(b) and (i)(c) (only with regard to the public pre-insolvency private plan procedure) referred to as the Insolvency Proceedings) referred to in section 1(1) of Regulation (EU) 2015/848 |
7/9
of 20 May 2015 on insolvency proceedings (recast) (the Insolvency Regulation), (e) the Company has not been dissolved (ontbonden), (f) the Company has not ceased to exist pursuant to a legal merger or demerger (juridische fusie of splitsing), and (g) no order for the administration (bewind) of the assets of the Company has been made; these assumptions are supported by our enquiries today with the Commercial Register, the Central Insolvency Register (Centraal Insolventieregister) and the EU Registrations list with the Central Insolvency Register and the court in Amsterdam and The Hague, which have not revealed any information that any such event has occurred with respect to the Company; however, such enquiries are not conclusive evidence that no such events have occurred; additionally, in the event a confidential pre-insolvency private plan procedure (onderhands akkoordprocedure) as referred to in paragraph (i)(c) should occur with respect to the Company, the above-mentioned registers will not make notice of such procedure;
(j) | Articles of Association: the Articles of Association have not been amended; |
(k) | Resolutions: the Resolutions (including the power of attorney in the Board Resolution) have not been revoked (ingetrokken) or amended and have not been and will not be declared null and void by a competent court and the Resolutions have not been, and will not be, amended, revoked (ingetrokken), terminated or declared null and void by a competent court and the factual statements and confirmations set out in the Resolutions are true and correct; |
(l) | Corporate Benefit: the entering into the Share Purchase Agreement and the Registration Rights Agreement and the transactions contemplated thereby are in the corporate interests (vennootschappelijk belang) of the Company; |
(m) | No Conflict of Interest: none of the members of the Board (in whatever capacity) has a direct or indirect personal conflict of interest with the Company (een direct of indirect persoonlijk belang dat strijdig is met het belang van de vennootschap en de met haar verbonden onderneming) in relation to the transactions contemplated by the Share Purchase Agreement and the Registration Rights Agreement; |
(n) | Works Council: no works council (ondernemingsraad) has been instituted with jurisdiction (and the authority to render advice) in respect of the Company and/or the transaction contemplated by the Share Purchase Agreement and the Registration Rights Agreement, nor has any person working for any enterprise (onderneming, as defined in the Dutch Works Councils Act (wet op de ondernemingsraden)) of the Company (whether employee or not) at any time made a request to the Board that any works council be installed; |
(o) | Financial Supervision Act: the Company is not required to be licensed pursuant to the Dutch Financial Supervision Act (Wet op het financieel toezicht); |
(p) | Due Execution: the signatures appearing on the Board Resolutions on behalf of the Company are the signatures of Daniel Wiegand, Dr. Thomas Enders, Henri Courpron, Barry Engle II, David Neeleman, Margaret Smyth, Gabrielle Toledano, David Wallerstein and Niklas Zennström; |
(q) | Signing under Power of Attorney: under any applicable law (other than Dutch law) governing the existence and extent of the signatories’ authority towards third parties |
8/9
(as determined pursuant to and in accordance with the rules of The Hague Convention of 14 March 1978 on the Laws Applicable to Agency), the power of attorney included in the Board Resolutions authorising the signatories creates valid and legally binding obligations for the Company towards any of the other parties to each of the Share Purchase Agreement and the Registration Rights Agreement as a result of the signatories acting as attorney for and on behalf of the Company;
(r) | Other Parties – Corporate Capacity/Approval: each of the parties to the Share Purchase Agreement and the Registration Rights Agreement (other than the Company) (i) has been validly incorporated, is validly existing and, to the extent relevant in such party’s jurisdiction, in good standing under the laws applicable to such party, (ii) has the power, capacity and authority to enter into, execute and deliver each of the Share Purchase Agreement and the Registration Rights Agreement to which it is a party and to exercise its rights and perform its obligations thereunder, and (iii) has duly authorised and validly executed and, to the extent relevant, delivered each of the Share Purchase Agreement and the Registration Rights Agreement to which it is a party; |
(s) | Anti-terrorism, Money Laundering: the parties to the Share Purchase Agreement and the Registration Rights Agreement comply with all applicable anti-terrorism, anti-corruption, anti-money laundering, sanctions and human rights laws and regulations, and the performance or enforcement of each of the Share Purchase Agreement and the Registration Rights Agreement is consistent with all such laws and regulations; without providing conclusive evidence, this assumption is supported by our online enquiry with the registers referred to in Sections 2:20(3) and 10:123 of the Dutch Civil Code finalised today confirming that the Company is not listed on any such list; |
(t) | No Director Disqualification: none of the directors of the Company is or, as applicable, at the time of execution of the Instruction Notice, the Share Purchase Agreement, the Registration Rights Agreement and the Board Resolutions will be subject to a civil law director disqualification (civielrechtelijk bestuursverbod) imposed by a court under articles 106a to 106e of the Dutch Bankruptcy Act (Faillissementswet) (as amended by the Directors disqualification act (Wet civielrechtelijk bestuursverbod)); although not providing conclusive evidence thereof, this assumption is supported by (i) the confirmation of the directors included in the Board Resolutions and (ii) our enquiries today with the Commercial Register; and |
(u) | Shares: the issue, offering, sale, transfer, payment and delivery of the New Shares, each distribution (electronically or otherwise) of any circulars, documents or information relating to the Company and/or the New Shares and any and all invitations, offers, offer advertisements, publications and other documents relating to the Transaction have been and will continue to be made in conformity with the provisions of the Share Purchase Agreement, the Registration Rights Agreement and the Registration Statement. |
9/9
Schedule 2
QUALIFICATIONS
Our opinion is subject to the following qualifications:
(a) | Insolvency Proceedings: a confirmation derived from an insolvency register does not provide conclusive evidence that an entity is not subject to any insolvency proceedings as defined in the Insolvency Regulation or otherwise; |
(b) | Creditor Action: our opinions with respect to the validity or enforceability of the Share Purchase Agreement and the Registration Rights Agreement or any legal act (rechtshandeling) forming part thereof or contemplated thereby are subject to and limited by the protection afforded by Dutch law to creditors whose interests have been adversely affected pursuant to the rules of Dutch law relating to (i) unlawful acts (onrechtmatige daden) based on Section 6:162 et seq. of the Dutch Civil Code (Burgerlijk Wetboek) and (ii) fraudulent conveyance or preference (actio pauliana) within the meaning of Section 3:45 of the Dutch Civil Code (Burgerlijk Wetboek) and/or Section 42 et seq. of the Dutch Bankruptcy Act (Faillissementswet); |
(c) | Foreign Documents: the opinion and other statements expressed herein relating to the Share Purchase Agreement and the Registration Rights Agreement are subject to the qualification that as Dutch lawyers we are not qualified or able to assess the true meaning and purport under applicable law (other than Dutch law) of the terms of the Share Purchase Agreement and the Registration Rights Agreement and the obligations thereunder of the parties thereto, and we have made no investigation of such meaning and purport; our review of the Share Purchase Agreement and the Registration Rights Agreement and any other documents subject or expressed to be subject to any law other than Dutch law has therefore been limited to the terms of such documents as they appear to us on the basis of such review and only in respect of any involvement of Dutch law; |
(d) | Sanctions Act 1977: the Sanctions Act 1977 (Sanctiewet 1977) and regulations promulgated thereunder, or international sanctions, may limit the enforceability of the Share Purchase Agreement and the Registration Rights Agreement; |
(e) | Non-assessable: in absence of an equivalent Dutch legal term for the term “non-assessable” as used in this opinion letter and for the purposes of this opinion letter, non-assessable means that no holder of shares can be required to pay any amount in addition to the amount required for such share to be fully paid as provided for by Section 2:81 of the Dutch Civil Code; and |
(f) | Commercial Register: an extract from the Commercial Register does not provide conclusive evidence that the facts set out in it are correct. However, under the 2007 Trade Register Act (Handelsregisterwet 2007), subject to limited exceptions, a legal entity cannot invoke the incorrectness or incompleteness of its Commercial Register information against third parties who were unaware of the incorrectness or incompleteness. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/03/22 Lilium N.V. POS AM 3:587K Toppan Merrill/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/06/22 Lilium N.V. 6-K 6/06/22 3:527K Toppan Merrill/FA 3/30/22 Lilium N.V. 20-F 12/31/21 169:21M Toppan Merrill/FA 11/18/21 Lilium N.V. S-8 11/18/21 5:374K Toppan Merrill/FA 9/29/21 Lilium N.V. F-1 208:24M Toppan Merrill/FA 9/20/21 Lilium N.V. 20-F 9/14/21 7:1.1M Toppan Merrill/FA 6/11/21 Lilium N.V. F-4/A 9:8.1M Toppan Merrill/FA 5/05/21 Lilium N.V. F-4 12:7.8M Toppan Merrill/FA |